Strategies for Accurate Diagnosis of Fetal Aortic Arch Anomalies: Benefits of Three-Dimensional Sonography With Spatiotemporal Image Correlation and a Novel Algorithm for Volume Analysis
CME Information: 1.00 credits
Release date: Nov 2018 Valid through: Nov 2019
Introduction/Statement of Need:
Obtaining an accurate diagnosis of fetal aortic arch anomalies is often difficult with traditional two-dimensional (2D) sonography. Thus, the aim of this study was to assess the value of three-dimensional (3D) sonography with spatiotemporal image correlation for diagnosing fetal aortic arch anomalies using a novel algorithm for 3D volume analysis.
This activity is designed for all cardiac sonographers and cardiovascular physicians with a primary interest and knowledge base in the field of echocardiography; in addition, residents, researchers, clinicians, intensivists, and other medical professionals.
At the end of this article the reader will better be able to:
Assess the value of three-dimensional sonography with spatiotemporal image correlation
Utilize 3D for better sensitivity and accuracy compared to 2D imaging for the detection of brachiocephalic anomalies
Effectively obtain 3D reconstructed images with high repeatability
Effectively use 3D spatiotemporal imaging for more accurate diagnosis of arch anomalies
The American Society of Echocardiography is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Society of Echocardiography designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC point in the American Board of Internal Medicine's (ABIM). Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.[CL1]
ARDMS, CCI and Sonography Canada recognize ASE’s certificates and have agreed to honor the credit hours toward their registry requirements for sonographers.
The American Society of Echocardiography is committed to ensuring that its educational mission and all sponsored educational programs are not influenced by the special interests of any corporation or individual, and its mandate is to retain only those authors whose financial interests can be effectively resolved to maintain the goals and educational integrity of the activity. While a monetary or professional affiliation with a corporation does not necessarily influence an author’s presentation, the Essential Areas and policies of the ACCME require that any relationships that could possibly conflict with the educational value of the activity be resolved prior to publication and disclosed to the audience. Disclosures of faculty and commercial support relationships, if any, have been indicated.
Yu Wang, MD, Miao Fan, PhD, Faiza Amber Siddiqui, PhD, Meilian Wang, PhD, Wei Sun, PhD, Xue Sun, MD, Wenjia Lei, MD and Ying Zhang, PhD, Shenyang and Guangzhou, China; and University Park, Pennsylvania.
According to ACCME policy, ASE implemented mechanisms to resolve all conflicts of interest prior to the planning and implementation of this activity.
The following authors reported no actual or potential conflicts of interest in relation to this document:
The following 2017-2018 ASE Board of Directors reviewed this document and reported no actual or potential conflicts of interest in relation to this document:
Reviewers included Jayashri Aragam, MD, FASE; Bonita Anderson, MApplSC, DMU, AMS, ACS, AFASA, FASE; Keith Collins, MS, RDCS, FASE; Gregory Ensing, MD, FASE; Alan Finley, MD, FASE; Edward Gill, MD, FASE; Amer Johri, MD, FASE; James Kirkpatrick, MD, FASE; Wyman Lai, MD, MPH, FASE; Jonathan Lindner, MD, FASE; G. Burkhard Mackensen, MD, PhD, FASE; Michael Main, MD, FASE; Elizabeth McIlwain, MPH, RCS, FASE; Carol Mitchell, PhD, RDMS, RDCS, RVT, RT(r), FASE; Geoffrey Rose, MD, FASE; Liza Sanchez, RCS, FASE; Elaine Shea, ACS, RCS, RCCS, FASE; Madhav Swaminathan, MD, FASE;
The following board and guidelines and standards committee members reported relationships with one or more commercial interests:
Judy Hung, MD, FASE – Chordalign, LLC (Scientific Advisory Board); Vera H. Rigolin, MD, FASE – Astra Zeneca (Stockownership), Bristol Myers Squibb (Stockownership), Celgene Corp (Stockownership), Merck Schering-Plough (Stockownership), Pfizer (Stockownership); James D. Thomas, MD, FASE – GE (Consultant/Advisor), Abbott (Consultant/Advisor), Edwards (Consultant/Advisor), Bay Labs (Consultant/Advisor); David Wiener, MD, FASE – Novitas (Consultant/Advisor)
The following ACCME reviewers, ASE Staff and CME editors reported no actual or potential conflicts of interest in relation to this document:
Tia Gordon, RDCS, FASE, Eric Kallstrom, ACS, RDCS, FASE and Christina LaFuria
The following ACCME reviewers, ASE Staff and CME editors reported relationships with one or more commercial interests:
Method of Participation: Online Only
Estimated Time to Complete this Activity: 1 hour
Receiving CME Credit:
To receive online CME credit for this activity, read the full activity then complete the posttest and evaluation. A score of 70% or higher is required for successful completion. You will be able to print your CME certificate immediately following successful completion of the posttest and evaluation.
You will need a compatible browser like Mozilla FireFox, Google Chrome or safari to view the content. Internet Explorer may not work.
This report is made available by ASE as a courtesy reference source for members. This report contains recommendations only and should not be used as the sole basis to make medical practice decisions or for disciplinary action against any employee. The statements and recommendations contained in this report are primarily based on the opinions of experts, rather than on scientifically verified data. ASE makes no express or implied warranties regarding the completeness or accuracy of the information in this report, including the warranty of merchantability or fitness for a particular purpose. In no event shall ASE be liable to you, your patients, or any other third parties for any decision made or action taken by you or such other parties in reliance on this information. Nor does your use of this information constitute the offering of medical advice by ASE or create any physician patient relationship between ASE and your patients or anyone else.
Copyright American Society of Echocardiography. Questions? Contact us at email@example.com
[CL1]Will only include if the review states that this activity meets the ABIM requirements.
1. Weinberg PM. Aortic arch anomalies. In: Allen HD, Driscoll DJ, Shaddy RE, Feltes TF, editors. Moss and Adams’ heart disease in infants, children, and adolescents: including the fetus and young adults. Philadel- phia: Lippincott Williams & Wilkins; 2008. pp. 731-60.
2. Hanneman K, Newman B, Chan F. Congenital variants and anomalies of the aortic arch. Radiographics 2017;37:32-51.
3. Bravo C, G,amez F, P,erez R, A, lvarez T, De Leo,n-Luis J. Fetal aortic arch anomalies: key sonographic views for their differential diagnosis and clin- ical implications using the cardiovascular system sonographic evaluation protocol. J Ultrasound Med 2016;35:237-51.
4. Edwards JE. Vascular rings related to anomalies of the aortic arches. Mod Concepts Cardiovasc Dis 1948;17:1.
5. Rauch R, Rauch A, Koch A, Zink S, Kaulitz R, Girisch M, et al. Laterality of the aortic arch and anomalies of the subclavian artery: reliable indicators for 22q11.2 deletion syndromes? Eur J Pediatr 2004;163:642-5.
6. Perolo A, De Robertis V, Cataneo I, Volpe N, Campobasso G, Frusca T, et al. Risk of 22q11.2 deletion in fetuses with right aortic arch and without intracardiac anomalies. Ultrasound Obstet Gynecol 2016;48:200-3.
7. Rembouskos G, Passamonti U, De Robertis V, Tempesta A, Campobasso G, Volpe G, et al. Aberrant right subclavian artery (ARSA) in unselected population at first and second trimester ultrasonography. Prenat Diagn 2012;32:968-75.
8. Yoo SJ, Min JY, Lee YH, Roman K, Jaeggi E, Smallhorn J. Fetal sonographic diagnosis of aortic arch anomalies. Ultrasound Obstet Gynecol 2003;22: 535-46.
9. Yagel S, Cohen SM, Shapiro I, Valsky DV. 3D and 4D ultrasound in fetal cardiac scanning: a new look at the fetal heart. Ultrasound Obstet Gynecol 2007;29:81-95.
10. American Institute of Ultrasound in Medicine. AIUM practice guideline for the performance of fetal echocardiography. J Ultrasound Med 2013;32:1067-82.
11. Zhang Y, Fan M, Ren WD, Xie LM, Ding CW, Sun W, et al. Prenatal diag- nosis of fetal unilateral lung agenesis complicated with cardiac malposition. BMC Pregnancy Childbirth 2013;13:79.
12. D’Antonio F, Khalil A, Zidere V, Carvalho JS. Fetuses with right aortic arch: a multicenter cohort study and meta-analysis. Ultrasound Obstet Gynecol 2016;47:423-32.
13. Razon Y, Berant M, Fogelman R, Amir G, Birk E. Prenatal diagnosis and outcome of right aortic arch without significant intracardiac anomaly. J Am Soc Echocardiogr 2014;27:1352-8.
14. Galindo A, Nieto O, Nieto MT, Rodr,ıguez-Mart,ın MO, Herraiz I, Escribano D, et al. Prenatal diagnosis of right aortic arch: associated find- ings, pregnancy outcome, and clinical significance of vascular rings. Prenat Diagn 2009;29:975-81.
15. Miranda JO, Callaghan N, Miller O, Simpson J, Sharland G. Right aortic arch diagnosed antenatally: associations and outcome in 98 fetuses. Heart 2014;100:54-9.
16. Ichikawa T, Koizumi J, Tanno K, Okochi T, Nomura T, Shimura S, et al. Kommerell diverticulum in adults: evaluation of routine CTexaminations. Tokai J Exp Clin Med 2016;41:65-9.
17. Arazin,ska A, Polguj M, Szymczyk K, Kaczmarska M, Tre˛ bin,ski q, Stefan,czyk L. Right aortic arch analysis—anatomical variant or serious vascular defect? BMC Cardiovasc Disord 2017;17:102.
18. De Leo,n-Luis J, Bravo C, G,amez F, Ortiz-Quintana L. Cardiovascular system sonographic evaluation algorithm: a new sonographic algorithm for evaluation of the fetal cardiovascular system in the second trimester. J Ul- trasound Med 2015;34:1271-82.